The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
Utilization of ejaculated or testicular sperm
Utilization of autologous or donor sperm
Utilization of donor oocytes
Utilization of gestational carrier
Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
Genomic Prediction Inc.
Lead sponsor
Boston IVF
Collaborator